VOYA Investment Management
ACAD icon

VOYA Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

VOYA Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.7M Sell
613,784
-27,727
-4% -$663K 0.01% 545
2025
Q4 		$17.1M Sell
641,511
-43,962
-6% -$1.05M 0.02% 538
2025
Q3 		$14.6M Buy
685,473
+26,637
+4% +$630K 0.01% 569
2025
Q2 		$14.2M Buy
658,836
+597,251
+970% +$11.1M 0.01% 631
2025
Q1 		$1.02M Buy
61,585
+25,418
+70% +$462K ﹤0.01% 1552
2024
Q4 		$664K Sell
36,167
-10,696
-23% -$173K ﹤0.01% 1812
2024
Q3 		$721K Sell
46,863
-5,386
-10% -$89.9K ﹤0.01% 1811
2024
Q2 		$849K Sell
52,249
-185,762
-78% -$3M ﹤0.01% 1711
2024
Q1 		$4.4M Sell
238,011
-57,563
-19% -$1.43M ﹤0.01% 1058
2023
Q4 		$9.25M Buy
295,574
+27,613
+10% +$659K 0.01% 774
2023
Q3 		$5.58M Buy
267,961
+272
+0.1% +$7.39K 0.01% 923
2023
Q2 		$6.41M Buy
267,689
+13,552
+5% +$301K 0.01% 897
2023
Q1 		$4.78M Sell
254,137
-250
-0.1% -$4.76K 0.01% 1009
2022
Q4 		$4.05M Buy
254,387
+5,549
+2% +$86.7K ﹤0.01% 1049
2022
Q3 		$4.07M Sell
248,838
-72,088
-22% -$1.17M ﹤0.01% 1034
2022
Q2 		$4.52M Buy
320,926
+272,673
+565% +$5.09M 0.01% 778
2022
Q1 		$1.17M Buy
48,253
+105
+0.2% +$2.54K ﹤0.01% 1381
2021
Q4 		$1.12M Buy
48,148
+369
+0.8% +$7.42K ﹤0.01% 1474
2021
Q3 		$794K Buy
47,779
+644
+1% +$12.4K ﹤0.01% 1746
2021
Q2 		$1.15M Sell
47,135
-32,716
-41% -$738K ﹤0.01% 1543
2021
Q1 		$2.06M Buy
79,851
+28,162
+54% +$1.24M ﹤0.01% 1172
2020
Q4 		$2.76M Sell
51,689
-592
-1% -$29.4K 0.01% 1007
2020
Q3 		$2.16M Buy
52,281
+5,345
+11% +$231K ﹤0.01% 1003
2020
Q2 		$2.27M Sell
46,936
-13,638
-23% -$655K 0.01% 977
2020
Q1 		$2.56M Sell
60,574
-559
-0.9% -$23K 0.01% 872
2019
Q4 		$2.62M Buy
61,133
+18,739
+44% +$815K 0.01% 999
2019
Q3 		$1.53M Sell
42,394
-2,672
-6% -$81K ﹤0.01% 1122
2019
Q2 		$1.21M Sell
45,066
-582
-1% -$14.9K ﹤0.01% 1257
2019
Q1 		$1.23M Buy
45,648
+5,307
+13% +$124K ﹤0.01% 1261
2018
Q4 		$652K Buy
40,341
+2,453
+6% +$47.6K ﹤0.01% 1561
2018
Q3 		$787K Hold
37,888
– – ﹤0.01% 1556
2018
Q2 		$579K Sell
37,888
-56,614
-60% -$1.01M ﹤0.01% 1723
2018
Q1 		$2.12M Buy
94,502
+9,494
+11% +$263K ﹤0.01% 1026
2017
Q4 		$2.56M Buy
85,008
+37,561
+79% +$1.2M 0.01% 982
2017
Q3 		$1.79M Buy
47,447
+9,678
+26% +$315K ﹤0.01% 1086
2017
Q2 		$1.05M Sell
37,769
-1,094
-3% -$32.6K ﹤0.01% 1348
2017
Q1 		$1.34M Sell
38,863
-1,687
-4% -$59.5K ﹤0.01% 1189
2016
Q4 		$1.17M Sell
40,550
-230,031
-85% -$6.09M ﹤0.01% 1241
2016
Q3 		$8.61K Sell
270,581
-446,277
-62% -$15.1M 0.02% 635
2016
Q2 		$23.3M Sell
716,858
-141,256
-16% -$4.73M 0.06% 308
2016
Q1 		$24M Buy
858,114
+133,650
+18% +$2.91M 0.06% 292
2015
Q4 		$25.8M Sell
724,464
-2,875
-0.4% -$101K 0.06% 277
2015
Q3 		$24.1M Sell
727,339
-25,550
-3% -$1.06M 0.06% 290
2015
Q2 		$31.5M Buy
752,889
+709,780
+1,646% +$27.5M 0.07% 263
2015
Q1 		$1.41M Hold
43,109
– – ﹤0.01% 1263
2014
Q4 		$1.37M Hold
43,109
– – ﹤0.01% 1250
2014
Q3 		$1.07M Hold
43,109
– – ﹤0.01% 1393
2014
Q2 		$974K Hold
43,109
– – ﹤0.01% 1507
2014
Q1 		$1.05M Hold
43,109
– – ﹤0.01% 1446
2013
Q4 		$1.08M Buy
43,109
+2,152
+5% +$50.8K ﹤0.01% 1416
2013
Q3 		$1.13M Hold
40,957
– – ﹤0.01% 1349
2013
Q2 		$743K Buy
+40,957
New +$564K ﹤0.01% 1558

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

VOYA Investment Management's ACAD Position: Q1 2026 in Review

VOYA Investment Management reduced its Acadia Pharmaceuticals (ACAD) stake by 4.3% in Q1 2026, selling an estimated $663K and leaving 613,784 shares worth $13.7M. The position accounts for 0.01% of the portfolio, ranked #545.

VOYA Investment Management first reported a position in ACAD in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.5M in Q2 2015. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • VOYA Investment Management held 613,784 shares of Acadia Pharmaceuticals worth $13.7M as of Q1 2026.
  • VOYA Investment Management sold 27,727 Acadia Pharmaceuticals shares in Q1 2026, an estimated $663K.
  • Acadia Pharmaceuticals made up 0.01% of VOYA Investment Management's portfolio in Q1 2026, its #545 holding.
  • VOYA Investment Management first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Acadia Pharmaceuticals position peaked at $31.5M in Q2 2015.
  • 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.